 Home > Medical News > Latest Medical News > First-line treatment of non-small cell lung cancer mRNA vaccine/PD-1 antibody combination is about to enter the clinic

First-line treatment of non-small cell lung cancer mRNA vaccine/PD-1 antibody combination is about to enter the clinic

 Last Update: 2022-04-30
 Source: Internet
 Author: User

Tags

clinical centrifuge

cell

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 9, BioNTech announced that it has expanded its strategic R&D cooperation with Regeneron, and will jointly promote the clinical trial of BioNTech's candidate cancer vaccine BNT116 in combination with the PD-1 inhibitor Libtayo (cemiplimab) for the treatment of advanced stage Non-small cell lung cancer (NSCLC) patients

BNT116 is a cancer vaccine developed based on BioNTech's FixVac technology platform

▲Introduction to FixVac technology platform (Image source: BioNTech official website)

Previously, the two companies have collaborated to evaluate the cancer vaccine BNT111 in combination with Libtayo in the treatment of advanced melanoma

References:

[1] BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.